Common Arthritis Drug Lowers Blood Pressure and Boosts Heart Health
Common Arthritis Drug Found To Lower Blood Pressure and Boost Heart HealthA medication millions already take for arthritis has a hidden benefit. New research shows a common arthritis drug can also lower blood pressure. This discovery could significantly improve heart health for many patients.Scientists in Australia led this promising study. They published their findings in the journal Annals of Medicine. The research focused on a drug called methotrexate. Doctors commonly prescribe it to treat rheumatoid arthritis.
The Study’s Key Findings
The team studied 62 patients with newly diagnosed rheumatoid arthritis. They randomly assigned the participants to two groups. One group received methotrexate. The other group took a different arthritis drug called sulfasalazine. The results after six months were clear. Patients on methotrexate saw a significant drop in their blood pressure. Their systolic blood pressure fell by an average of 7.4 mmHg. Systolic pressure is the top number in a reading. It measures the pressure in arteries when the heart beats. This reduction is clinically meaningful. “Even a small drop in blood pressure can lower the risk of serious heart problems,” explained lead researcher Professor Arduino Mangoni. These problems include heart attacks and strokes.
Why This Benefit Matters
Researchers found this effect was independent. The blood pressure drop was not linked to improved arthritis symptoms. It also wasn’t tied to changes in artery stiffness. Therefore, the drug may help the heart in other ways. It could be calming inflammation throughout the body. It might also be improving overall blood vessel health. “We’ve known for a while that methotrexate helps with inflammation,” said Professor Mangoni. “But now we’re seeing that it may also help lower blood pressure”. This is a major risk factor for heart disease. The findings offer an extra layer of protection for arthritis patients. They already face a higher risk of cardiovascular issues due to chronic inflammation.
Personalized Treatment in the Future?
The study also revealed a genetic link. Certain gene variants made some people more likely to get this benefit. This opens the door for personalized medicine.In the future, doctors might use genetic tests. They could identify which patients will gain the most heart benefits from methotrexate. However, senior researcher Sara Tommasi notes that further study is needed. Scientists want to confirm these findings. They also need to figure out the exact mechanism behind the blood pressure reduction.
